Earnings History Data for Cidara Therapeutics, Inc. (CDTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
03-08-2023 AH CDTX Cidara Therapeutics 94.00 -0.14 -0.08 0.00 Cidara Therapeutics GAAP EPS of -$0.14 misses by $0.01, revenue of $7.61M misses by $3.94M
[8/3/2023 5:37 PM]		 0.9620 -0.06 
(-5.69%)		 1.00 -0.02 
(-1.96%)		 0.46 - 2.10 499,700 750,000 2,868
23-03-2023 PM CDTX Cidara Therapeutics 142.00 -0.19 -0.01 0.00 Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04, revenue of $10.22M misses by $0.35M
[3/23/2023 7:53 AM]		 1.44 -0.46 
(-24.47%)		 1.69 -0.21 
(-11.05%)		 0.40 - 2.10 11,465,800 5,400,000 1,212,380
03-11-2022 AH CDTX Cidara Therapeutics 41.00 0.17 0.30 0.00 Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10, revenue of $40.74M beats by $18.06M
[11/3/2022 5:51 PM]		 0.5620 -0.01 
(-1.92%)		 0.58 0.01 
(1.22%)		 0.40 - 1.76 195,098 220,000 7,276
09-08-2022 AH CDTX Cidara Therapeutics 48.00 -0.19 -0.28 0.00 Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M
[8/9/2022 5:25 PM]		 0.6525 0.03 
(4.38%)		 0.65 0.02 
(3.95%)		 0.40 - 2.39 439,944 1,490,000 2,143
11-05-2022 AH 5:40 PM ET
(May 11)		 CDTX Cidara Therapeutics 50.00 -0.27 -0.26 0.00 Cidara Therapeutics GAAP EPS of -$0.27 beats by $0.01, revenue of $7.11M beats by $2.4M
[5/11/2022 4:56 PM]		 0.4601 -0.13 
(-22.65%)		 0.55 -0.04 
(-7.43%)		 0.41 - 2.39 1,135,300 190,000 5,036
07-03-2022 AH CDTX Cidara Therapeutics 47.00 -0.26 -0.33 0.00 Cidara Therapeutics GAAP EPS of -$0.26, revenue of $7.2M
[3/7/2022 6:07 PM]		 0.7140 0.05 
(7.00%)		 0.0 0.0 
(0.00%)		 0.63 - 3.08 225,799 200,000 0
10-11-2021 AH CDTX Cidara Therapeutics 78.00 -0.37 -0.37 0.00 Cidara Therapeutics EPS misses by $0.02, beats on revenue
[11/10/2021 4:42 PM]		 1.52 -0.01 
(-0.65%)		 1.55 0.02 
(1.31%)		 1.46 - 3.15 415,161 470,000 1,130
13-05-2021 AH 4:45 PM ET
(May 13)		 CDTX Cidara Therapeutics, Inc. 97.06 -0.39 -0.17 -0.46 Cidara Therapeutics EPS misses by $0.05, misses on revenue
[5/13/2021 5:17 PM]		 2.00 -0.02 
(-0.99%)		 2.01 -0.01 
(-0.50%)		 1.76 - 4.45 266,999 480,000 9,286
05-11-2020 AH 4:50 PM ET
(Nov 5)		 CDTX Cidara Therapeutics, Inc. 104.82 -0.41 -0.48 0.08 Cidara Therapeutics EPS misses by $0.01, misses on revenue
[11/5/2020 5:35 PM]		 2.34 -0.20 
(-7.87%)		 2.50 0.02 
(0.81%)		 1.30 - 4.45 287,372 212,399 230
13-08-2020 AH CDTX Cidara Therapeutics, Inc. 165.70 -0.45 -0.23 -0.49 Cidara Therapeutics EPS misses by $0.14, misses on revenue
[8/13/2020 4:59 PM]		 3.78 0.0 
(0.00%)		 0.0 0.0 
(0.00%)		 1.22 - 4.45 104,321 203,500 0
13-05-2020 AH After the close
(May 13)		 CDTX Cidara Therapeutics, Inc. 132.39 -0.46 -0.34 -0.60 Cidara Therapeutics EPS misses by $0.12, beats on revenue
[5/13/2020 4:58 PM]		 2.99 0.07 
(2.40%)		 2.95 0.03 
(1.03%)		 1.22 - 4.44 146,384 293,949 320